Cite
MLA Citation
Thomas Herzog et al.. “TP025/#1399 Artistry-7: phase 3 multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.” International journal of gynecological cancer, vol. 32, n.d., p. A235. http://access.bl.uk/ark:/81055/vdc_100170500844.0x000032